HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Caplin Point Laboratories’ arm acquires Neoethicals Chile SpA
Apr-02-2025

Caplin Point Laboratories’ subsidiary -- Caplin Point Far East has acquired Neoethicals Chile SpA. The company’s subsidiary has acquired 3000 equity shares of Neoethicals Chile SpA at the face value of One Thousand Chilean Peso per share (equivalent to $3000). 

Recently, the Caplin Point Far East’s board had approved the investment in Neoethicals Chile SpA through the purchase of all its shares.

Caplin Point Laboratories is the mid-sized company in India’s pharmaceutical sector to be engaged in the manufacture of APIs, finished formulations, research & development, clinical research, frontend generic presence in Latin America, brand marketing in Francophone Africa and an USFDA approved injectable facility. 


  RELATED NEWS >>